Royal Bank of Canada »

Cellectar Biosciences shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-03-31 $10k 2.5k 4.00

More positions owned by Royal Bank of Canada

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Tc Energy Corp (TRP)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Enbridge (ENB)
Canadian Natural Resources (CNQ)

View all positions for Royal Bank of Canada

Top funds holding Cellectar Biosciences

AIGH Capital Management
Nantahala Capital Management
Vanguard Group
ADAR1 Capital Management
Rosalind Advisors
Barclays
Geode Capital Management
Citadel Advisors
Hudson Bay Capital Management
BlackRock
Lighthouse Investment Partners
Jane Street
Northern Trust
Susquehanna International
Goss Wealth Management

View all funds holding Cellectar Biosciences